Showing 1 - 9 results of 9 for search 'Jia−Ying Zhou', query time: 0.04s
Refine Results
-
1
-
2
Remodeling of hyperpolarization-activated current, Ih, in Ah-type visceral ganglion neurons following ovariectomy in adult rats. by Guo-Fen Qiao, Zhao Qian, Hong-Li Sun, Wen-Xiao Xu, Zhen-Yu Yan, Yang Liu, Jia-Ying Zhou, Hao-Cheng Zhang, Li-Juan Wang, Xiao-Dong Pan, Yili Fu
Published 2013-01-01
Article -
3
Visible-Light-Mediated Catalyst-Free [2+2] Cycloaddition Reaction for Dihydrocyclobuta[<i>b</i>]naphthalene-3,8-diones Synthesis under Mild Conditions by Hong-Bo Tan, Jia-Ying Zhou, Ying-Shan Liu, Tong Lei, Shi-Yu Wang, Shuang-Shuang Hu, Xu Zhang, Zhi-Gang Xu, Dian-Yong Tang, Zhong-Zhu Chen, Bo-Chu Wang
Published 2023-11-01
Article -
4
Comprehensive Characterization of Immune Landscape Based on Epithelial-Mesenchymal Transition Signature in OSCC: Implication for Prognosis and Immunotherapy by Si-yuan Zhang, Xian-yue Ren, Chun-yang Wang, Xi-juan Chen, Ruo-yan Cao, Qin Liu, Xue Pan, Jia-ying Zhou, Wei-lin Zhang, Xin-Ran Tang, Bin Cheng, Tong Wu
Published 2021-07-01
Article -
5
Clinical characteristics and prognostic value of the KRAS G12C mutation in Chinese non-small cell lung cancer patients by Si-Yang Liu, Hao Sun, Jia-Ying Zhou, Guang-Ling Jie, Zhi Xie, Yang Shao, Xian Zhang, Jun-Yi Ye, Chun-Xiang Chen, Xu-Chao Zhang, Qing Zhou, Jin-Ji Yang, Yi-Long Wu
Published 2020-06-01
Article -
6
Concomitant genetic alterations having greater impact on the clinical benefit of EGFR‐TKIs in EGFR‐mutant advanced NSCLC than BIM deletion polymorphism by Si‐Yang Liu, Jia‐Ying Zhou, Wen‐Feng Li, Hao Sun, Yi‐Chen Zhang, Hong‐Hong Yan, Zhi‐Hong Chen, Chun‐Xiang Chen, Jun‐Yi Ye, Jin‐Ji Yang, Qing Zhou, Xu‐Chao Zhang, Yi‐Long Wu
Published 2020-03-01
Article -
7
Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma by Hao Sun, Si-Yang Liu, Jia-Ying Zhou, Jin-Tian Xu, Huang-Kai Zhang, Hong-Hong Yan, Jiao-Jiao Huan, Ping-Ping Dai, Chong-Rui Xu, Jian Su, Yan-Fang Guan, Xin Yi, Rong-Shan Yu, Wen-Zhao Zhong, Yi-Long Wu
Published 2020-10-01
Article -
8
MET amplification identified by next-generation sequencing and its clinical relevance for MET inhibitors by Lun-Xi Peng, Guang-Ling Jie, An-Na Li, Si-Yang Liu, Hao Sun, Mei-Mei Zheng, Jia-Ying Zhou, Jia-Tao Zhang, Xu-Chao Zhang, Qing Zhou, Wen-Zhao Zhong, Jin-Ji Yang, Hai-Yan Tu, Jian Su, Hong-Hong Yan, Yi-Long Wu
Published 2021-11-01
Article -
9
Intratumoral genetic and immune microenvironmental heterogeneity in T4N0M0 (diameter ≥ 7 cm) non‐small cell lung cancers by Jia−Tao Zhang, Song Dong, Li−Yan Ji, Jia−Ying Zhou, Zhi− Hong Chen, Jian Su, Qing−Ge Zhu, Meng−Min Wang, E−E. Ke, Hao Sun, Xue−Tao Li, Jin−Ji Yang, Qing Zhou, Xu− Chao Zhang, Xuan Gao, Xue−Ning Yang, Xuefeng Xia, Xin Yi, Wen−Zhao Zhong, Yi−Long Wu
Published 2022-05-01
Article